If you planned around 2 August 2026 as the date the high-risk obligations bite, the timetable has changed. What has not changed: three sets of obligations already apply, and one of them landed in August 2026 and reaches almost any SaaS company using AI.
What Actually Changed
The Digital Omnibus on AI, given final approval by the Council on 29 June 2026 and published in the Official Journal, amends Regulation (EU) 2024/1689 and postpones the application dates for the high-risk obligations. Standalone Annex III systems moved to 2 December 2027 (a 16-month deferral), and AI embedded in regulated products under Annex I moved to 2 August 2028 (a 12-month deferral).
But the Article 50 transparency duties and the enforcement powers over GPAI model providers were not postponed, and they apply from 2 August 2026. The fines in the Act remain up to €35 million or 7% of global turnover, whichever is higher.
What Already Applies to You Today
Three layers are live right now, regardless of the postponement:
1. The bans on prohibited practices under Article 5, in force since February 2025. The Omnibus even added new prohibited categories.
2. GPAI provider obligations under Article 53, applicable since August 2025, with the Commission's enforcement powers over them taking effect in August 2026.
3. The Article 50 transparency duties, from 2 August 2026. This is the layer most often missed, and the most relevant one for SaaS companies: a system interacting directly with people must disclose that it is an AI, and synthetic or deep-fake content must be labelled. If you have a chatbot on your site or a feature that generates content, this applies to you now.
A Postponement Is Not an Exemption
This is the part worth internalising. Your system's classification did not change, only the date the obligations are enforced. A system that is high-risk under Annex III is still high-risk, and the requirements that will apply to it in December 2027 are the same requirements. What the deferral buys is preparation time, and building a technical documentation file and running a conformity assessment takes months, not weeks.
The expensive mistake here is reading the deferral as the topic coming off the agenda, and then starting to prepare in October 2027.
Use our free checker to find your classification and the obligations that apply to you, in English or Hebrew, in a few short questions.
What a High-Risk System Will Require When the Date Arrives
The category includes AI-powered recruitment and CV screening tools, credit scoring systems, critical infrastructure management, and AI products in healthcare, education, and law enforcement. Every provider or importer of such a system into the EU market will need:
- Complete technical documentation — system card, architecture, dataset description, and pre-deployment testing records
- Conformity assessment — for certain categories, conducted by an accredited Notified Body
- EU database registration — every high-risk system must be registered in the European Commission's official database
- Human oversight mechanism — documented evidence that humans can understand, monitor, and intervene in the AI's decisions
- Declaration of Conformity and CE marking for hardware-embedded AI products
These timelines are the updated dates following the Digital Omnibus: December 2027 for Annex III, and August 2028 for Annex I.
Why Israeli Companies Face Elevated Risk
The EU AI Act applies to any entity — including Israeli companies — that markets an AI product to users in the EU, regardless of physical presence in Europe. Israeli SaaS companies, startups with European customers, and API developers selling to European integrators are all within scope.
What makes 2026 especially demanding: the EDPB has declared this the year of GDPR transparency enforcement (Articles 12–14). Regulatory pressure is arriving from two directions simultaneously — the AI Act and GDPR — targeting the same European customers.
4 Actions Israeli Companies Must Take Now
1. Map Your AI Systems by Risk Level
Conduct an internal inventory of every AI system your company develops, sells, or uses. Determine whether it falls under one of the eight High-Risk categories listed in Annex III of the Act. This is your starting point.
2. Build Your Technical Documentation File
For each high-risk system, prepare Technical Documentation in accordance with Annex IV. Without complete documentation, conformity assessment is impossible. GPAI providers (such as LLMs used as a component) must also prepare a Summary of Training Data.
3. Assess Whether External Certification Is Required
Biometric systems, healthcare AI products, and critical infrastructure systems require conformity assessment by a Notified Body. Lead times are long — do not wait.
4. Consider ISO/IEC 42001 as a Compliance Lever
There is approximately 70% overlap between ISO 42001 (AI management systems) and EU AI Act requirements. For Israeli companies, certification is a powerful signal to European partners that you meet the law's demands.
How Lawyerit Works on This
Lawyerit guides Israeli technology companies through EU AI Act, GDPR, and Amendment 13 compliance. System mapping, documentation file construction, and engagement with Notified Bodies. We know the path.
Contact us today for a no-cost initial consultation.
Frequently asked questions
Does the EU AI Act apply to Israeli companies?
Yes. The Act applies to any entity that markets an AI product to users in the EU, regardless of physical presence in Europe.
What is the difference between a "high-risk" and a "limited-risk" AI system?
High-risk systems (Annex III) include AI for recruitment, credit scoring, infrastructure management, healthcare, and more, requiring complete documentation, conformity assessment, and EU database registration. Those obligations were postponed to 2 December 2027. Limited-risk systems mainly carry the Article 50 transparency duties, which already apply from 2 August 2026.
How does ISO/IEC 42001 help with EU AI Act compliance?
There is approximately 70% overlap between ISO 42001 (AI management system) requirements and the EU AI Act, making certification a significant compliance foundation.
The above is general information only and does not constitute legal advice. For guidance tailored to your specific circumstances — talk to us.
Sources
Want to know what applies to your company?
Talk to us